New treatment regimen may prevent fatal leukemia progression
10/09/2013
Two gene alterations pair up to promote the growth of leukemia cells and their escape from anti-cancer drugs, according to a study in The Journal of Experimental Medicine. Chronic myeloid leukemia (CML) is an aggressive cancer of the blood that is often treated with a drug called Imatinib (a.k.a. Gleevec)...
Improving nutritional status before bladder cancer surgery improves outcomes
10/09/2013
Patients with bladder cancer are two times more likely to have complications after a radical cystectomy procedure if they have a biomarker for poor nutritional status before the operation, according to study findings presented at the 2013 Clinical Congress of the American College of Surgeons...
The human body favors nanodiscs over nanorods
10/09/2013
For years scientists have been working to fundamentally understand how nanoparticles move throughout the human body. One big unanswered question is how the shape of nanoparticles affects their entry into cells. Now researchers have discovered that under typical culture conditions, mammalian cells prefer disc-shaped nanoparticles over those shaped like rods...
Pancreatic cancer: chemo drug Gemzar improves survival rates
10/09/2013
People who have had surgery to remove pancreatic cancer may benefit from better survival time, without the disease progressing, if they are treated with the drug gemcitabine for 6 months after surgery, a study has shown...
Women with early-stage breast cancer in one breast are increasingly opting to undergo a more aggressive operation to remove both breasts called contralateral prophylactic mastectomy (CPM)...
Justin E. Bekelman, M.D...
Nipple injections to treat breast cancer
10/08/2013
Doctors in Boston, MA, are investigating the possibility of administering drugs directly into the milk ducts via the nipple to treat breast cancer. According to the American Cancer Society, breast cancer is the second most common cancer among American women after skin cancers. They estimate that 1 in 8 women will develop invasive breast cancer during their lifetimes...
Nipple injections to treat breast cancer
10/08/2013
Doctors in Boston, MA, are investigating the possibility of administering drugs directly into the milk ducts via the nipple to treat breast cancer. According to the American Cancer Society, breast cancer is the second most common cancer among American women after skin cancers. They estimate that 1 in 8 women will develop invasive breast cancer during their lifetimes...
A better way to make antibody-guided therapies
10/08/2013
Chemists at The Scripps Research Institute (TSRI) have devised a new technique for connecting drug molecules to antibodies to make advanced therapies...
Myriad's myRisk Hereditary Cancer™ test improves colon cancer testing by 60 percent
10/08/2013
Myriad Genetics, Inc. (NASDAQ: MYGN) has announced new clinical data from a study with myRisk Hereditary Cancer, a 25-gene hereditary cancer panel, that showed a 60 percent increase in mutations detected in cancer predisposition genes in patients with a prior history of colon cancer and/or polyps.